Valuation OneSource Specialty Pharma Limited
Stocks
ONESOURCE
INE013P01021
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,653.20 INR | +0.24% |
|
+1.62% | -8.69% |
Company Valuation: OneSource Specialty Pharma Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 200,521 | 189,532 | - | - |
| Change | - | -5.48% | - | - |
| Enterprise Value (EV) 1 | 200,521 | 180,604 | 198,388 | 190,696 |
| Change | - | -9.93% | -0.97% | -3.88% |
| P/E | -1,075x | -229x | 45.8x | 22.2x |
| PBR | - | 3.26x | 3.02x | 2.67x |
| PEG | - | -1x | -0x | 0x |
| Capitalization / Revenue | - | 11.9x | 8.5x | 5.59x |
| EV / Revenue | - | 12.7x | 8.89x | 5.62x |
| EV / EBITDA | - | 59.4x | 25.4x | 14.1x |
| EV / EBIT | - | 719x | 36.1x | 18.8x |
| EV / FCF | - | -32.2x | 50.8x | 26.1x |
| FCF Yield | - | -3.1% | 1.97% | 3.83% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -1.63 | -6.44 | 36.1 | 74.58 |
| Distribution rate | - | - | - | - |
| Net sales 1 | - | 14,216 | 22,304 | 33,914 |
| EBITDA 1 | - | 3,042 | 7,822 | 13,560 |
| EBIT 1 | - | 251.3 | 5,495 | 10,145 |
| Net income 1 | -179.7 | -738 | 4,134 | 8,540 |
| Net Debt 1 | - | 11,733 | 8,856 | 1,164 |
| Reference price 2 | 1,752.25 | 1,653.20 | 1,653.20 | 1,653.20 |
| Nbr of stocks (in thousands) | 114,436 | 114,646 | - | - |
| Announcement Date | 05/05/25 | 13/05/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -168.12x | 14.94x | 72.08x | - | 1.97B | |
| 34.29x | 6.01x | 18.57x | 0.96% | 49.18B | |
| -23.34x | 351.51x | -21.46x | -.--% | 39.58B | |
| 46.99x | 4.73x | 30.33x | -.--% | 34.69B | |
| 25.1x | 2.78x | 12.03x | -.--% | 34.42B | |
| 27.15x | 7.96x | 19.98x | 0.42% | 27.11B | |
| 31.75x | 5.12x | 23.3x | -.--% | 15.36B | |
| 24.41x | 2.07x | 9.09x | 1.1% | 14.05B | |
| 24.03x | 1.91x | 11.58x | -.--% | 13.02B | |
| Average | 2.47x | 44.11x | 19.50x | 0.31% | 25.49B | |
| Weighted average by Cap. | 20.95x | 64.72x | 12.43x | 0.33% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ONESOURCE Stock
- Valuation OneSource Specialty Pharma Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
